Equities

Surgery Partners Inc

Surgery Partners Inc

Actions
  • Price (EUR)28.00
  • Today's Change0.600 / 2.19%
  • Shares traded--
  • 1 Year change+6.87%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024 07:04 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments196283390
Total Receivables, Net496456430
Total Inventory757161
Prepaid expenses313126
Other current assets, total977939
Total current assets895921946
Property, plant & equipment, net1,2241,156954
Goodwill, net4,3264,1373,912
Intangibles, net554244
Long term investments18419089
Note receivable - long term------
Other long term assets10314459
Total assets6,8776,6826,118
LIABILITIES
Accounts payable172152125
Accrued expenses220190215
Notes payable/short-term debt000
Current portion long-term debt/capital leases736360
Other current liabilities, total5889137
Total current liabilities523493537
Total long term debt2,7022,5592,878
Total debt2,7752,6222,939
Deferred income tax------
Minority interest1,3751,2851,211
Other liabilities, total290347403
Total liabilities4,8904,6845,029
SHAREHOLDERS EQUITY
Common stock1.301.300.90
Additional paid-in capital2,4982,4781,622
Retained earnings (accumulated deficit)(569)(557)(503)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total5876(32)
Total equity1,9871,9981,089
Total liabilities & shareholders' equity6,8776,6826,118
Total common shares outstanding12712689
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.